Copyright
©The Author(s) 2020.
World J Gastroenterol. Mar 14, 2020; 26(10): 1067-1079
Published online Mar 14, 2020. doi: 10.3748/wjg.v26.i10.1067
Published online Mar 14, 2020. doi: 10.3748/wjg.v26.i10.1067
Table 1 Characteristics of 432 hepatitis B virus-infected patients in different fibrosis stages diagnosed by liver biopsy (mean ± SD)
Variables | Fibrosis stage | P value | |||
F0-F1 | F2 | F3 | F4 | ||
Cases, n | 95 | 126 | 103 | 108 | / |
Male, n (%) | 62 (65.26) | 88 (69.84) | 82 (79.61) | 89 (82.41) | / |
Age (yr) | 37.91 ± 10.71 | 36.52 ± 11.11 | 41.71 ± 10.01 | 46.63 ± 9.95 | < 0.001c |
HBV DNA (IU/mL) | 1.26 × 108 ± 3.64 ×108 | 1.33 × 108 ± 4.01 × 108 | 6.39 × 107 ± 1.62 × 108 | 5.63 × 107 ± 1.56 × 108 | 0.229 |
AFP (ng/mL) | 3.20 ± 3.01 | 19.37 ± 100.27 | 12.56 ± 23.25 | 40.98 ± 160.29 | 0.118 |
ALT (IU/L) | 42.58 ± 61.49 | 125.21 ± 211.29 | 263.82 ± 421.57 | 115.84 ± 165.90 | < 0.001c |
AST (IU/L) | 30.45 ± 39.36 | 85.65 ± 171.17 | 185.61 ± 292.67 | 92.18 ± 127.81 | < 0.001c |
GGT (IU/L) | 31.59 ± 26.74 | 42.10 ± 50.37 | 78.13 ± 107.06 | 64.47 ± 68.93 | < 0.001c |
ALP (IU/L) | 75.63 ± 21.27 | 81.56 ± 31.47 | 109.30 ± 120.10 | 103.82 ± 41.55 | 0.002b |
PLT (109/L) | 206.91 ± 51.14 | 198.36 ± 55.72 | 185.36 ± 58.29 | 134.95 ± 46.41 | < 0.001c |
Total bilirubin (μmol/L) | 13.09 ± 5.30 | 18.34 ± 16.99 | 29.93 ± 31.44 | 22.67 ± 12.60 | < 0.001c |
Indirect bilirubin (μmol /L) | 7.78 ± 4.31 | 8.40 ± 9.40 | 13.46 ± 17.05 | 10.01 ± 7.94 | 0.003b |
Total protein (g/L) | 73.46 ± 4.78 | 73.61 ± 10.53 | 72.48 ± 11.14 | 74.44 ± 7.66 | 0.635 |
Albumin (g/L) | 45.80 ± 3.30 | 45.44 ± 4.40 | 45.33 ± 6.51 | 44.39 ± 5.39 | 0.320 |
- Citation: Cao X, Shang QH, Chi XL, Zhang W, Xiao HM, Sun MM, Chen G, An Y, Lv CL, Wang L, Nan YM, Chen CY, Tan ZN, Liu XE, Zhuang H. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus. World J Gastroenterol 2020; 26(10): 1067-1079
- URL: https://www.wjgnet.com/1007-9327/full/v26/i10/1067.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i10.1067